ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Madopar DR, Tabletten - 30 Tablette(n)
53493017 Roche Pharma (Schweiz) AG
Madopar DR, Tabletten29.10.1996
  29.10.1996
Levodopa and Decarboxylase Inhibitor (N04BA02)12.02.2004
WHO-DDD 
01.08.30 Tablette(n)
01.08. 
B  
Yes 
IPCI
17.19No
    
10 %35.10
7680534930177Synthetika
1904293 
Composition
levodopum 200.000 mg, benserazidum 50.000 mg ut benserazidi hydrochloridum, hypromellosum, mannitolum, E 172 (rubrum), povidonum K 30, magnesii stearas, silica colloidalis hydrica, ricini oleum hydrogenatum, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 2.9 mg, pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Benserazide50 mg
Levodopa200 mg
BAG: Active AgentDose
Benserazide50 mg
Levodopa200 mg
 
Inactive agentsDoseadditional_information
(Rubrum)  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 172 color.
Hypromellosum  
Magnesii Stearas  
Mannitol  
Povidonum K30  
Pro Compresso  
Ricini Oleum Hydrogenatum  
Silica Colloidalis Hydrica  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home